3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Smoldering Multiple Myeloma
3
Monoclonal Gammopathy of Undetermined Significance
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Multiple Myeloma
2
Uterine Cervical Dysplasia
1
Thrombocythemia, Essential
1
Rectal Neoplasms
1
Psychological Well-Being
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Neurofibromatosis 1
1
Neoplasms
1
Myelodysplastic Syndromes
1
Motor Activity
1
Lung Neoplasms
1
Joint Diseases
1
Gastritis, Atrophic
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Castration Sensitive Prostate Cancer
1
Breast Neoplasms
1
Arthralgia
1
Interventions
Cyclophosphamide
9
mogamulizumab
6
Biopsy
6
fludarabine
5
fludarabine phosphate
4
Specimen Handling
4
Immunoglobulin G
4
Disulfides
4
Brentuximab Vedotin
4
ruxolitinib
3
romidepsin
3
pembrolizumab
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Etoposide
3
Busulfan
3
hypericin
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Prednisone
2
Nivolumab
2
Melphalan
2
Depsipeptides
2
tofacitinib
1
thymoglobulin
1
tazemetostat
1
talimogene laherparepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
Curcumin
×
1 year
×
Clear all
No trials found.